IWM
IBB icon

IHT Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

IHT Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Buy
1,710
+40
+2% +$6.88K 0.01% 989
2026
Q1 		$282K Buy
1,670
+16
+1% +$2.74K 0.01% 1027
2025
Q4 		$279K Buy
1,654
+30
+2% +$4.87K 0.01% 986
2025
Q3 		$235K Sell
1,624
-779
-32% -$106K 0.01% 1050
2025
Q2 		$304K Sell
2,403
-720
-23% -$88.4K 0.01% 884
2025
Q1 		$399K Sell
3,123
-362
-10% -$49.1K 0.01% 745
2024
Q4 		$461K Sell
3,485
-1,273
-27% -$179K 0.01% 710
2024
Q3 		$691K Sell
4,758
-1,960
-29% -$284K 0.02% 612
2024
Q2 		$922K Sell
6,718
-971
-13% -$130K 0.03% 453
2024
Q1 		$1.06M Buy
7,689
+2,834
+58% +$387K 0.04% 407
2023
Q4 		$660K Sell
4,855
-1,388
-22% -$169K 0.03% 511
2023
Q3 		$763K Buy
6,243
+2,149
+52% +$273K 0.04% 414
2023
Q2 		$520K Sell
4,094
-649
-14% -$84.3K 0.03% 524
2023
Q1 		$613K Sell
4,743
-270
-5% -$35.3K 0.04% 445
2022
Q4 		$658K Buy
5,013
+2
+0% +$258 0.04% 406
2022
Q3 		$586K Buy
5,011
+2,044
+69% +$254K 0.04% 407
2022
Q2 		$349K Buy
2,967
+253
+9% +$30K 0.03% 480
2022
Q1 		$354K Buy
2,714
+128
+5% +$16.7K 0.03% 519
2021
Q4 		$395K Sell
2,586
-131
-5% -$20.3K 0.03% 506
2021
Q3 		$439K Buy
2,717
+284
+12% +$47.8K 0.04% 464
2021
Q2 		$398K Sell
2,433
-198
-8% -$30.5K 0.03% 615
2021
Q1 		$396K Buy
2,631
+15
+0.6% +$2.38K 0.03% 536
2020
Q4 		$396K Sell
2,616
-222
-8% -$31.7K 0.03% 484
2020
Q3 		$384K Buy
2,838
+36
+1% +$4.88K 0.04% 409
2020
Q2 		$383K Buy
2,802
+702
+33% +$89.5K 0.05% 349
2020
Q1 		$226K Sell
2,100
-120
-5% -$13.8K 0.03% 458
2019
Q4 		$268K Sell
2,220
-2,481
-53% -$277K 0.03% 477
2019
Q3 		$468K Sell
4,701
-866
-16% -$90.7K 0.06% 327
2019
Q2 		$607K Sell
5,567
-407
-7% -$43.3K 0.09% 250
2019
Q1 		$668K Sell
5,974
-1,103
-16% -$121K 0.11% 215
2018
Q4 		$682K Sell
7,077
-899
-11% -$95.4K 0.13% 188
2018
Q3 		$973K Buy
7,976
+128
+2% +$15.1K 0.21% 125
2018
Q2 		$862K Buy
7,848
+885
+13% +$94.6K 0.22% 126
2018
Q1 		$714K Sell
6,963
-130
-2% -$14.4K 0.19% 138
2017
Q4 		$769K Buy
7,093
+520
+8% +$55.6K 0.2% 132
2017
Q3 		$744K Buy
6,573
+5,043
+330% +$539K 0.32% 84
2017
Q2 		$3K Buy
1,530
+750
+96% +$73.9K ﹤0.01% 1172
2017
Q1 		$75K Buy
780
+159
+26% +$15.2K 0.05% 330
2016
Q4 		$56K Buy
+621
New +$56.5K 0.04% 371

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

IHT Wealth Management's IBB Position: Q2 2026 in Review

IHT Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 2.4% in Q2 2026, buying an estimated $6.88K and bringing the position to 1,710 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #989.

IHT Wealth Management first reported a position in IBB in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.06M in Q1 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • IHT Wealth Management held 1,710 shares of iShares Biotechnology ETF worth $325K as of Q2 2026.
  • IHT Wealth Management bought 40 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.88K.
  • iShares Biotechnology ETF made up 0.01% of IHT Wealth Management's portfolio in Q2 2026, its #989 holding.
  • IHT Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 39 quarters since.
  • IHT Wealth Management's iShares Biotechnology ETF position peaked at $1.06M in Q1 2024.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.